BILLERICA, Mass.--(BUSINESS WIRE)--HydroCision® Inc. (www.hydrocision.com) announced today that it has been awarded U.S. Patent No. 7,122,017 for the novel use of fluidjet devices in ‘open’ and Minimally Invasive Surgery (MIS). Fluidjet products using HydroCision’s proprietary technology have now been successfully used in more than 15,000 spine, arthroscopic and wound debridement procedures combined—thus firmly establishing HydroSurgery as a major platform in surgery. The Company’s family of fluidjet products covered in its expanding worldwide intellectual property portfolio empowers surgeons to simultaneously cut, ablate, and remove hard and soft tissue quickly, safely, and effectively— without the collateral thermal or mechanical trauma of other surgical modalities.
